Production of Stable Electrically Conductive PVDF Membranes Based on Polydopamine-Polyethyleneimine-Assisted Deposition of Carbon Nanotubes.

Electrically conductive membranes (ECMs) have emerged as a multifunctional separation technology that integrates membrane filtration with electrochemical reactions. Physical stability remains a critical challenge for ECMs synthesized by coating polymer membranes with conductive materials. In this article, polydopamine (PDA) and polyethyleneimine (PEI) were used to facilitate the synthesis of significantly more stable ECMs using poly(vinylidene fluoride) (PVDF) ultrafiltration membranes and carbon nanotubes (CNTs). Four different synthesis methods were compared in terms of the final surface stability and separation properties: (1) CNTs deposited on PEI-crosslinked PDA-coated PVDF membranes, (2) PEI-crosslinked CNTs deposited on PDA-coated PVDF, (3) PDA, PEI and CNTs sequentially deposited layer-by-layer on PVDF, and (4) PEI-crosslinked PDA deposited on CNT-coated PVDF. The results revealed that method 1 generated ECMs with the greatest physical stability, highest electrical conductivity (18,518 S/m), and sufficient permeability (395.2 L/(m2·h·bar). In comparison, method 2 resulted in membranes with the highest permeability (2128.5 L/(m2·h·bar), but with low surface conductivity (502 S/m) and poor physical stability (i.e., 53-75% lower peel-off forces compared to other methods). Overall, methods 1, 3, and 4 can be used to make highly conductive membranes with a 97-99% removal of methyl orange by electrochemical degradation at -3 V.

Effect of Preoperative Antianxiety Medications on Blood Pressure and Blood Loss in Total Knee Arthroplasty: A Case-Control Study.

Background: The increasing number of canceled operations in patients undergoing total knee arthroplasty (TKA) due to high blood pressure readings has put a considerable burden on surgeons. In this study, we aim to assess the effect of giving antianxiety drugs preoperatively on maintaining blood pressure (BP) and blood loss for patients undergoing TKA surgery. Methods: This retrospective case-control study included patients who underwent total knee arthroplasty and divided them into two main groups: those who had taken a 3 mg bromazepam oral tablet at the night preoperatively and the control group. The blood pressure of patients was then measured preoperatively (baseline), in the morning of surgery, in the operating room before anesthesia, and during the surgery. The percentage of measured BP was calculated by dividing the measured BP by the baseline, then multiplying by 100. Results: 301 patients were included in our study: 137 received bromazepam and 164 as a control group. The ratio of systolic BP (SBP) in the morning of surgery to the baseline (percentage of morning SBP) decreased significantly in the bromazepam group compared with the controls. The ratio of SBP, in the operating room before anesthesia (percentage of preanesthesia SBP) also decreased significantly in the bromazepam group. However, the percentage of SBP in the middle of surgery did not change significantly. In addition, there was a significant difference change from the baseline in diastolic BP and mean arterial BP between the two groups in the morning of surgery, inside the theatre, and in the middle of the operation. The bromazepam group also showed a significant decrease in blood loss. Conclusion: Preoperative oral antianxiety drugs (bromazepam) helps in controlling hemodynamic changes associated with anxiety, including maintaining BP in well-controlled hypertensive and healthy patients undergoing TKA, and it plays a role in decreasing the total blood loss.

An empirical determination of the whole-life cost of FO-based open-loop wastewater reclamation technologies.

Over the past 5-10 years it has become apparent that the significant energy benefit provided by forward osmosis (FO) for desalination arises only when direct recovery of the permeate product from the solution used to transfer the water through the membrane (the draw solution) is obviated. These circumstances occur specifically when wastewater purification is combined with saline water desalination. It has been suggested that, for such an "open loop" system, the FO technology offers a lower-cost water reclamation option than the conventional process based on reverse osmosis (RO). An analysis is presented of the costs incurred by this combined treatment objective. Three process schemes are considered combining the FO or RO technologies with membrane bioreactors (MBRs): MBR-RO, MBR-FO-RO and osmotic MBR (OMBR)-RO. Calculation of the normalised net present value (NPV/permeate flow) proceeded through developing a series of empirical equations based on available individual capital and operating cost data. Cost curves (cost vs. flow capacity) were generated for each option using literature MBR and RO data, making appropriate assumptions regarding the design and operation of the novel FO and OMBR technologies. Calculations revealed the MBR-FO-RO and OMBR-RO schemes to respectively offer a ∼20% and ∼30% NPV benefit over the classical MBR-RO scheme at a permeate flow of 10,000 m3  d-1, provided the respective schemes are applied to high and low salinity wastewaters. Outcomes are highly sensitive to the FO or OMBR flux sustained: the relative NPV benefit (compared to the classical system) of the OMBR-RO scheme declined from 30% to ∼4% on halving the OMBR flux from a value of 6 L m-2. h-1.